Elevated Adrenocorticotropic Hormone After Adrenalectomy or Adrenal Ablation and Immune Checkpoint Inhibitors: Adrenal Insufficiency Is Not Always the Culprit.

David Shabsovich, Nikhita Kathuria-Prakash, Jiajia Zhang, Marsenne Cabral, Lidia Lopez, Amit Sumal, Alexandra Drakaki

Abstract readCase Reports

In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

David ShabsovichInternal Medicine, University of California Los Angeles, Los Angeles, USA.

Nikhita Kathuria-PrakashHematology-Oncology, University of California Los Angeles, Los Angeles, USA.

Jiajia ZhangInternal Medicine, University of California Los Angeles, Los Angeles, USA.

Marsenne CabralHematology-Oncology, University of California Los Angeles, Los Angeles, USA.

Lidia LopezHematology-Oncology, University of California Los Angeles, Los Angeles, USA.

Amit SumalEndocrinology, University of California Los Angeles, Los Angeles, USA.

Alexandra DrakakiHematology-Oncology, University of California Los Angeles, Los Angeles, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adrenal insufficiency is a known complication of both immune checkpoint inhibitors (ICIs) and resection or ablation of the adrenal glands. In the modern era of immunotherapy, more frequent assessment of the adrenal hormonal axis is performed after initiation of ICIs in order to monitor for such complications. The interpretation of these laboratory tests, such as elevated adrenocorticotropic hormone (ACTH), in patients who receive ICIs and undergo adrenalectomy or adrenal ablation provides an additional set of diagnostic challenges that are not well described. We present a case series of four patients who had elevated ACTH without clinical (symptoms) or biochemical (decreased cortisol) evidence of adrenal insufficiency, a pattern suggesting a compensatory increase in ACTH. This highlights an emerging phenomenon and diagnostic challenge in the monitoring of the adrenal axis in patients undergoing adrenalectomy or ablation alongside ICI therapy, emphasizing the need for close follow-up and thorough investigation to rule out adrenal insufficiency in such patients.

Indexed as

acthadrenalectomyadrenal insufficiency (ai)cancer immunotherapyhematology-oncology

Identifiers

PMID40636645

DOI10.7759/cureus.85573

PMCPMC12237831

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.